These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 2874690)

  • 1. Nervous system control mechanisms in heart failure.
    Cohn JN
    Acta Med Scand Suppl; 1986; 707():15-20. PubMed ID: 2874690
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurohumoral control mechanisms in congestive heart failure.
    Cohn JN; Levine TB; Francis GS; Goldsmith S
    Am Heart J; 1981 Sep; 102(3 Pt 2):509-14. PubMed ID: 6115571
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contribution of vasopressin to vasoconstriction in patients with congestive heart failure: comparison with the renin-angiotensin system and the sympathetic nervous system.
    Creager MA; Faxon DP; Cutler SS; Kohlmann O; Ryan TJ; Gavras H
    J Am Coll Cardiol; 1986 Apr; 7(4):758-65. PubMed ID: 3514728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The contributions of sympathetic tone and the renin-angiotensin system to severe chronic congestive heart failure: response to specific inhibitors (prazosin and captopril).
    Kluger J; Cody RJ; Laragh JH
    Am J Cardiol; 1982 May; 49(7):1667-74. PubMed ID: 7044087
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A clinical study on the role of the renin-angiotensin-aldosterone system and catecholamines in chronic congestive heart failure.
    Nishioka A; Kubo S; Hirota Y; Kawamura K; Takatsu T
    Jpn Heart J; 1982 Jul; 23(4):527-44. PubMed ID: 6752473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The neurohumoral axis in congestive heart failure.
    Francis GS; Goldsmith SR; Levine TB; Olivari MT; Cohn JN
    Ann Intern Med; 1984 Sep; 101(3):370-7. PubMed ID: 6147109
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Baroreceptor-mediated release of vasopressin in patients with chronic congestive heart failure and defective sympathetic responsiveness.
    Manthey J; Dietz R; Opherk D; Osterziel KJ; Leinberger H; Kübler W
    Am J Cardiol; 1992 Jul; 70(2):224-8. PubMed ID: 1626511
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dissociation of the responses of the renin-angiotensin system and sympathetic nervous system to a vasodilator stimulus in congestive heart failure.
    Levine TB; Olivari MT; Cohn JN
    Int J Cardiol; 1986 Aug; 12(2):165-73. PubMed ID: 3744598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurohumoral mechanisms involved in congestive heart failure.
    Francis GS
    Am J Cardiol; 1985 Jan; 55(2):15A-21A. PubMed ID: 2857062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurohumoral vasoconstrictor systems in heart failure.
    Riegger AJ
    Eur Heart J; 1985 Jun; 6(6):479-89. PubMed ID: 2864248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Neurohormonal assessment in heart failure: from the sophisticated laboratory to practical indications].
    Dei Cas L; Metra M; Visioli O
    G Ital Cardiol; 1993 Feb; 23(2):193-204. PubMed ID: 8098306
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Abnormalities of peripheral sympathetic nervous system control in congestive heart failure.
    Cohn JN
    Circulation; 1990 Aug; 82(2 Suppl):I59-67. PubMed ID: 1973641
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of the renin-angiotensin system in the development of congestive heart failure in the dog as assessed by chronic converting-enzyme blockade.
    Riegger GA; Liebau G; Holzschuh M; Witkowski D; Steilner H; Kochsiek K
    Am J Cardiol; 1984 Feb; 53(4):614-8. PubMed ID: 6320625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contributions of neuroendocrine and local autocrine-paracrine mechanisms to the pathophysiology and pharmacology of congestive heart failure.
    Dzau VJ
    Am J Cardiol; 1988 Sep; 62(8):76E-81E. PubMed ID: 2901216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pathophysiology of left heart failure with reference to hemodynamic and neurohumoral changes].
    Schmieder RE
    Acta Med Austriaca; 1992; 19(3):77-82. PubMed ID: 1357906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of bromocriptine in patients with congestive heart failure.
    Francis GS; Parks R; Cohn JN
    Am Heart J; 1983 Jul; 106(1 Pt 1):100-6. PubMed ID: 6346844
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activity of the sympathetic nervous system and renin-angiotensin system assessed by plasma hormone levels and their relation to hemodynamic abnormalities in congestive heart failure.
    Levine TB; Francis GS; Goldsmith SR; Simon AB; Cohn JN
    Am J Cardiol; 1982 May; 49(7):1659-66. PubMed ID: 7044086
    [No Abstract]   [Full Text] [Related]  

  • 18. Mechanisms and implications of autonomic nervous system dysfunction in heart failure.
    Middlekauff HR
    Curr Opin Cardiol; 1997 May; 12(3):265-75. PubMed ID: 9243084
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abnormal neurohumoral response to nitroprusside infusion in congestive heart failure.
    Olivari MT; Levine TB; Cohn JN
    J Am Coll Cardiol; 1983 Sep; 2(3):411-7. PubMed ID: 6875105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurohormonal activation and the response to converting enzyme inhibitors in congestive heart failure.
    Kubo SH
    Circulation; 1990 Feb; 81(2 Suppl):III107-14. PubMed ID: 2137052
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.